Before you call, check out the companies that are making headlines. Nvidia shares fell 2%, extending losses from Thursday, when Nvidia shares fell 3.5%. The decline comes after the AI chip maker briefly overtook Microsoft as the most valuable public company on Tuesday. Sarepta Therapeutics – Shares of the biopharmaceutical company rose 37% after the U.S. Food and Drug Administration approved Sarepta Elevidys gene therapy, which will treat patients with Duchenne muscular dystrophy. Traditionally, the therapy has been approved for all patients four years of age or older who can walk, and those who cannot walk have been given accelerated approval. Nike – Shares of the sportswear maker rose 1% after the Oppenheimer upgrade, outperforming the market. The firm also restored Nike as a leader among mega-cap companies, saying the company’s shares will gradually recover as the company refocuses on product innovation and brand building. Asana — Shares jumped more than 3% after the software company announced a $150 million stock buyback plan. The Company expects its share repurchase program to continue through June 30, 2025. Gilead Sciences – Pharmaceutical stocks rose more than 2.6%, building on an 8.5% gain from the previous session. Gilead announced Thursday that its HIV prevention vaccine was successful in a late-stage study. LendingTree – Shares in the online lending market fell slightly after Bloomberg reported that hackers are now auctioning off stolen data from the site. LendingTree was the victim of a cyberattack on cloud computing company Snowflake. Apple – Shares of the iPhone maker jumped 1 point after a price increase on the Bernstein exchange. Analyst Toni Sacconaghi says the more optimistic outlook stems from his view that Apple could be a leader in the artificial intelligence boom rather than a “laggard.” Delta Air Lines – Shares rose 0.7% following news Thursday that the airliner announced a quarterly dividend of 15 cents per share, a 50% increase from previous levels. — CNBC’s Brian Evans, Michelle Fox, Jesse Pound and Sarah Min contributed reporting.
